Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Retention | 8 | 2021 | 32 | 3.640 |
Why?
|
| Suburethral Slings | 6 | 2023 | 21 | 3.480 |
Why?
|
| Pelvic Organ Prolapse | 6 | 2022 | 26 | 3.130 |
Why?
|
| Urinary Incontinence | 7 | 2023 | 44 | 2.120 |
Why?
|
| Phenazopyridine | 3 | 2021 | 6 | 1.850 |
Why?
|
| Urinary Incontinence, Stress | 5 | 2023 | 25 | 1.780 |
Why?
|
| Anesthetics, Local | 4 | 2021 | 71 | 1.770 |
Why?
|
| Urinary Bladder | 5 | 2020 | 45 | 1.650 |
Why?
|
| Gynecologic Surgical Procedures | 7 | 2018 | 47 | 1.410 |
Why?
|
| Urodynamics | 2 | 2021 | 13 | 1.340 |
Why?
|
| Postoperative Complications | 5 | 2021 | 1303 | 1.250 |
Why?
|
| Urination | 3 | 2021 | 13 | 0.820 |
Why?
|
| Urinary Catheterization | 2 | 2020 | 19 | 0.810 |
Why?
|
| Psyllium | 1 | 2022 | 5 | 0.770 |
Why?
|
| Nomograms | 1 | 2021 | 18 | 0.730 |
Why?
|
| Translating | 1 | 2021 | 18 | 0.720 |
Why?
|
| Pudendal Nerve | 1 | 2021 | 4 | 0.710 |
Why?
|
| Anesthetics | 1 | 2021 | 14 | 0.700 |
Why?
|
| Bupivacaine | 2 | 2021 | 35 | 0.700 |
Why?
|
| Gynecology | 1 | 2021 | 54 | 0.690 |
Why?
|
| Telephone | 1 | 2021 | 119 | 0.690 |
Why?
|
| Urology | 1 | 2021 | 45 | 0.680 |
Why?
|
| Uterine Prolapse | 4 | 2014 | 16 | 0.680 |
Why?
|
| Nerve Block | 1 | 2021 | 53 | 0.660 |
Why?
|
| Female | 28 | 2023 | 32789 | 0.620 |
Why?
|
| Ultrasonography | 2 | 2020 | 483 | 0.600 |
Why?
|
| Middle Aged | 21 | 2021 | 17551 | 0.590 |
Why?
|
| Patient Satisfaction | 2 | 2021 | 433 | 0.590 |
Why?
|
| Suture Techniques | 2 | 2017 | 101 | 0.570 |
Why?
|
| Pelvic Floor | 1 | 2017 | 10 | 0.540 |
Why?
|
| Pain, Postoperative | 4 | 2017 | 163 | 0.540 |
Why?
|
| Neuromuscular Agents | 2 | 2009 | 16 | 0.540 |
Why?
|
| Sutures | 1 | 2017 | 42 | 0.540 |
Why?
|
| Botulinum Toxins, Type A | 2 | 2009 | 19 | 0.530 |
Why?
|
| Analgesics | 2 | 2015 | 102 | 0.480 |
Why?
|
| Hysterectomy | 1 | 2015 | 69 | 0.460 |
Why?
|
| Adult | 13 | 2021 | 16782 | 0.450 |
Why?
|
| Humans | 29 | 2023 | 63298 | 0.450 |
Why?
|
| Preoperative Care | 4 | 2019 | 192 | 0.420 |
Why?
|
| Treatment Outcome | 10 | 2023 | 5657 | 0.420 |
Why?
|
| Case-Control Studies | 4 | 2019 | 1121 | 0.420 |
Why?
|
| Cesarean Section | 1 | 2014 | 99 | 0.410 |
Why?
|
| Prospective Studies | 5 | 2021 | 3285 | 0.380 |
Why?
|
| Aged | 14 | 2021 | 14392 | 0.350 |
Why?
|
| Disease Management | 1 | 2013 | 232 | 0.350 |
Why?
|
| Double-Blind Method | 3 | 2021 | 738 | 0.330 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2009 | 7 | 0.310 |
Why?
|
| Adnexa Uteri | 1 | 2006 | 2 | 0.260 |
Why?
|
| Hypesthesia | 1 | 2006 | 9 | 0.260 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2006 | 14 | 0.260 |
Why?
|
| Leg | 1 | 2006 | 87 | 0.250 |
Why?
|
| Postoperative Care | 2 | 2021 | 123 | 0.250 |
Why?
|
| Pelvis | 2 | 2008 | 59 | 0.250 |
Why?
|
| Postoperative Period | 3 | 2015 | 138 | 0.240 |
Why?
|
| Fascia Lata | 1 | 2005 | 2 | 0.240 |
Why?
|
| Vesicovaginal Fistula | 1 | 2004 | 2 | 0.220 |
Why?
|
| Retrospective Studies | 6 | 2019 | 6631 | 0.220 |
Why?
|
| Catheters, Indwelling | 2 | 2016 | 69 | 0.220 |
Why?
|
| Vagina | 1 | 2004 | 83 | 0.220 |
Why?
|
| Urinary Tract Infections | 2 | 2016 | 90 | 0.210 |
Why?
|
| Cost-Benefit Analysis | 2 | 2023 | 311 | 0.210 |
Why?
|
| Logistic Models | 2 | 2018 | 1275 | 0.200 |
Why?
|
| Defecation | 1 | 2022 | 17 | 0.190 |
Why?
|
| Dietary Fiber | 1 | 2022 | 75 | 0.180 |
Why?
|
| Premedication | 1 | 2021 | 20 | 0.180 |
Why?
|
| Risk Factors | 5 | 2015 | 5341 | 0.160 |
Why?
|
| Pain | 1 | 2022 | 406 | 0.150 |
Why?
|
| Aged, 80 and over | 6 | 2016 | 5447 | 0.150 |
Why?
|
| Anesthesia, General | 1 | 2018 | 46 | 0.140 |
Why?
|
| Pain Measurement | 2 | 2017 | 345 | 0.140 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 1146 | 0.140 |
Why?
|
| Tensile Strength | 1 | 2017 | 30 | 0.140 |
Why?
|
| Materials Testing | 1 | 2017 | 85 | 0.130 |
Why?
|
| Administration, Oral | 1 | 2018 | 369 | 0.130 |
Why?
|
| Postmenopause | 2 | 2016 | 237 | 0.130 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 1084 | 0.120 |
Why?
|
| Estrogens | 1 | 2016 | 116 | 0.120 |
Why?
|
| Drainage | 1 | 2016 | 154 | 0.120 |
Why?
|
| Cross-Over Studies | 2 | 2016 | 161 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 2571 | 0.110 |
Why?
|
| Colposcopy | 1 | 2014 | 20 | 0.110 |
Why?
|
| Endometrium | 1 | 2014 | 30 | 0.110 |
Why?
|
| Body Mass Index | 1 | 2018 | 863 | 0.110 |
Why?
|
| Gestational Age | 1 | 2014 | 189 | 0.110 |
Why?
|
| Pregnancy | 2 | 2014 | 2330 | 0.110 |
Why?
|
| Wounds and Injuries | 2 | 2006 | 247 | 0.100 |
Why?
|
| Hematoma | 1 | 2013 | 80 | 0.100 |
Why?
|
| Postpartum Period | 1 | 2014 | 195 | 0.100 |
Why?
|
| Diabetes, Gestational | 1 | 2014 | 140 | 0.100 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2012 | 7 | 0.100 |
Why?
|
| Urogenital Surgical Procedures | 1 | 2012 | 5 | 0.100 |
Why?
|
| Gastrointestinal Motility | 1 | 2012 | 8 | 0.100 |
Why?
|
| Constipation | 1 | 2012 | 15 | 0.090 |
Why?
|
| Surgical Wound Infection | 1 | 2013 | 115 | 0.090 |
Why?
|
| Time Factors | 2 | 2017 | 3762 | 0.090 |
Why?
|
| Internet | 1 | 2015 | 469 | 0.090 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 474 | 0.090 |
Why?
|
| Diagnostic Techniques, Urological | 1 | 2010 | 4 | 0.090 |
Why?
|
| Urologic Surgical Procedures | 1 | 2010 | 44 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 784 | 0.080 |
Why?
|
| Analgesics, Opioid | 1 | 2014 | 536 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2005 | 2460 | 0.080 |
Why?
|
| Incidence | 1 | 2013 | 1375 | 0.080 |
Why?
|
| Cystocele | 1 | 2008 | 1 | 0.080 |
Why?
|
| Genitalia, Female | 1 | 2007 | 17 | 0.070 |
Why?
|
| Polyuria | 1 | 2005 | 1 | 0.060 |
Why?
|
| Urination Disorders | 1 | 2005 | 8 | 0.060 |
Why?
|
| Sacrococcygeal Region | 1 | 2005 | 8 | 0.060 |
Why?
|
| Urinary Bladder Diseases | 1 | 2005 | 10 | 0.060 |
Why?
|
| Iliac Vein | 1 | 2005 | 9 | 0.060 |
Why?
|
| Dissection | 1 | 2005 | 48 | 0.060 |
Why?
|
| Blood Vessels | 1 | 2005 | 62 | 0.060 |
Why?
|
| Transplantation, Homologous | 1 | 2005 | 243 | 0.060 |
Why?
|
| Cadaver | 1 | 2005 | 128 | 0.060 |
Why?
|
| Arteries | 1 | 2005 | 81 | 0.060 |
Why?
|
| Cystoscopy | 1 | 2004 | 17 | 0.060 |
Why?
|
| Young Adult | 1 | 2014 | 4683 | 0.050 |
Why?
|
| Adolescent | 1 | 2014 | 6238 | 0.050 |
Why?
|
| Quality of Life | 2 | 2016 | 1226 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2005 | 382 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 2180 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 1543 | 0.040 |
Why?
|
| Lactobacillus | 1 | 2016 | 7 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2016 | 163 | 0.030 |
Why?
|
| Equipment Design | 1 | 2016 | 349 | 0.030 |
Why?
|
| Self Care | 1 | 2016 | 212 | 0.030 |
Why?
|
| Biopsy | 1 | 2014 | 444 | 0.020 |
Why?
|
| Dioctyl Sulfosuccinic Acid | 1 | 2012 | 2 | 0.020 |
Why?
|
| Laxatives | 1 | 2012 | 3 | 0.020 |
Why?
|
| Cathartics | 1 | 2012 | 7 | 0.020 |
Why?
|
| Nonprescription Drugs | 1 | 2012 | 17 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 735 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 196 | 0.020 |
Why?
|
| Decision Making | 1 | 2015 | 407 | 0.020 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2012 | 129 | 0.020 |
Why?
|
| Pedigree | 1 | 2008 | 193 | 0.020 |
Why?
|
| Tissue Adhesions | 1 | 2007 | 20 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 1276 | 0.010 |
Why?
|
| Phenotype | 1 | 2008 | 1200 | 0.010 |
Why?
|
| Prevalence | 1 | 2005 | 1377 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 1618 | 0.010 |
Why?
|
| Aging | 1 | 2005 | 746 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 2164 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2005 | 2568 | 0.010 |
Why?
|
| Mice | 1 | 2008 | 10827 | 0.010 |
Why?
|
| Animals | 1 | 2008 | 20631 | 0.010 |
Why?
|
| Male | 1 | 2008 | 29819 | 0.000 |
Why?
|